1.646.889.1200|info@lifescipublicrelations.com

Phase I Gives Hope for First Zika Vaccine

//Phase I Gives Hope for First Zika Vaccine

Phase I Gives Hope for First Zika Vaccine

Results from a Phase I trial showed promising safety and efficacy of a potential first vaccine against the mosquito-borne Zika virus, developed by French biotech Valneva and US biopharma Emergent BioSolutions.

By | 2018-11-26T11:12:17-04:00 November 20th, 2018|News|Comments Off on Phase I Gives Hope for First Zika Vaccine

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.